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Infection with Epstein–Barr virus (EBV) usually leads to a latent state in B lymphocytes. The virus can be reactivated through two viral
transactivators, Zta and Rta, leading to a cascade of gene expression. An EBV DNA array was generated to analyze the pattern of transcription of
the entire EBV genome under various conditions. Firstly, a complete set of temporal expression clusters of EBV genes was displayed by analyzing
the array data of anti-IgG-induced Akata cells. In addition to assigning genes of unknown function to the various clusters, increasing expression of
latent genes, including EBNA2, EBNA3A and EBNA 3C, was observed during virus replication. Secondly, gene expression independent of viral
DNA replication was analyzed in PAA blocked Akata cells and in chemically induced Raji cells. Several genes with presumed late functions were
found to be expressed with early kinetics and independent of viral DNA replication, suggesting possible novel functions for these genes. Finally,
the EBV array was used to identify Rta responsive gene expression in Raji cells, and in the EBV-positive epithelial cells NA, using a Zta siRNA
strategy. The array data were confirmed by Northern blotting, RT-PCR and reporter assays. All the information here thus provides a better
understanding of the control of EBV lytic gene expression.
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Epstein–Barr virus (EBV) belongs to the gamma-1 sub-
family of human herpesviruses. Primary infection with EBV in
early childhood usually is asymptomatic, whereas infection in
adolescence may result in infectious mononucleosis (IM), an
immunopathologic disease caused by proinflammatory cyto-
kines, which usually is self-limited. The virus can then cause a
life-long persistent infection which may be associated with
many malignancies, including Burkitt’s lymphoma, gastric
carcinoma, nasopharyngeal carcinoma (NPC), T-cell lympho-
ma, Hodgkin’s disease and PTLD-like lymphoma and leio-
myosarcoma in immunocompromised individuals (reviewed by
Rickinson and Kieff, 2001).
EBV latent genes, including EBNA-2 and LMP-1, have
been shown to contribute to transformation and growth of host0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: mrc@ha.mc.ntu.edu.tw (M.-R. Chen).cells in vitro, and it was a general belief that neoplastic changes
were attributable to the latent status of the virus (Rickinson and
Kieff, 2001). However, elevated serum antibodies against EBV
lytic proteins were detected in patients with EBV associated
malignancies, and the serum viral load is considered to be a
valuable prognostic marker for NPC patients following
radiotherapy (Liu et al., 1997, 2000; Lin et al., 2004). These
observations strongly suggest EBV reactivation at a pre-tumor
stage in some malignancies, such as NPC. Reactivation of EBV
begins with the expression of two immediate early transacti-
vators, Zta (BZLF1) and Rta (BRLF1), which can be
transcribed in the presence of protein synthesis inhibitors
(Biggin et al., 1987; Takada and Ono, 1989). Upon lytic
induction, Zta and Rta are able to function in synergy to turn on
the expression of downstream genes. Zta binds to AP1-like
motifs present in the promoter upstream region of many early
genes, as well as that of BRLF1 (Adamson and Kenney, 1998;
Farrell et al., 1989; Flemington and Speck, 1990). Rta can
transactivate target promoters either by direct binding to the6) 358 – 372
www.e
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through an indirect cellular signaling pathway, such as
phosphatidylinositol-3 kinase activation (Darr et al., 2001).
Thus, the activity of Rta-dependent promoters is more difficult
to predict than for Zta-dependent promoters.
In contrast to the extensive studies on the functions of
latent genes and the initiation of lytic reactivation, our
understanding of the expression and function of EBV lytic
genes is much less comprehensive. Based on the basic
replication strategy shared by human herpesviruses, many
EBV genes were assigned putative functions according to the
genomic organization or partial sequence homology with other
herpesvirus genes. However, some apparently well-conserved
proteins were recently found to have functions different to or
distinct from those that had been predicted. For example,
glycoprotein gB is important for herpes simplex virus (HSV)
entry but not for virus assembly or egress (Roizman and Sears,
2001), whereas EBV gB was demonstrated to play an
important role in capsid formation and virus release, in
addition to virus-cell fusion (Herrold et al., 1996; Lee and
Longnecker, 1997; Haan et al., 2001). BILF1 had been
predicted to encode a structural gp64; however, it was recently
demonstrated by two different groups to be a G-protein-
coupled receptor (Beisser et al., 2005; Paulsen et al., 2005).
Thus, we believe that a detailed picture of the EBV gene
transcription program would be beneficial for understanding
not only the control of virus replication but also the molecular
mechanism of EBV pathogenesis.
The nucleotide sequence of the 172-kb EBV genome,
containing approximately 85 putative open reading frames
(ORFs), was first published by Baer et al. (1984) and the
complete viral genome was recently revised (de Jesus et al.,
2003). Investigation of the expression control of individual
genes under various stimuli is difficult because of the large
genome size. Although partial gene expression patterns in
some EBV-positive cell lines have been evaluated by Northern
blotting (Biggin et al., 1987; Laux et al., 1988; Takada and
Ono, 1989), the time points and number of genes detected were
limited. For instance, only seven BamHI fragments were used
as probes in Northern blotting to analyze the gene expression
profile of Akata EBV (currently considered to be wild-type,
Takada and Ono, 1989). In order to monitor simultaneously the
genome-wide gene expression control, a DNA microarray
containing all EBV ORFs was developed in our laboratory and
designated as the NTU_EBVArray. It makes feasible obtaining
an overall EBV gene expression program in anti-human IgG-
induced Akata cells. The hierarchical clustering of array data
not only provides information regarding the control of viral
gene expression, but also suggests functions for uncharacter-
ized viral genes according to their coordinated expression with
genes involved in similar functions. The genes with early
kinetics also were examined in Akata in the presence of the
DNA polymerase inhibitor PAA, and in chemically induced
Raji cells. Finally, because Rta responsive promoters were
difficult to predict, the Rta-induced overall EBV gene
expression also was examined by ectopic expression of Rta
in Raji cells.Results
Construction, specificity and reproducibility of the
NTU_ EBVArray
The NTU_EBVArray consists of 96 elements, including 87
EBV sequences from 85 ORFs, 6 cellular and 3 plant genes.
Three EBV ORFs deleted from the B95-8 strain, namely, Raji
LF1, LF2 and LF3 (Parker et al., 1990), also were included. The
specificity of the NTU_EBVArray was accessed by hybridizing
RNA extracted from EBV-negative Akata cells (Shimizu et al.,
1994). As expected, all the spots of EBV genes and plant genes
showed no hybridization signals, while explicit signals were
detected unambiguously in all six cellular controls, including
S26, GAPDH, a-tubulin, h-actin, DAD-1 and HP (data not
shown). The reproducibility of this array was examined with the
gene expression profiles of EBV-positive Akata cells at 6 h post
anti-IgG induction (Fig. 1A). Data from three separate experi-
ments for each condition were compared by scatter plot
analysis. The correlation coefficients between each two sets of
the three independent experiments in EBV replicating Akata
cells were 0.9759 (Fig. 1A), 0.9474 and 0.9576. A desirable
reproducibility of NTU_EBVArray was guaranteed by the
correlation scores obtained from the six aforementioned plots.
The genome-wide gene expression cascade in anti-human
IgG-induced Akata cells
To gain an overview of EBV gene expression, RNA was
harvested from anti-human IgG-induced EBV-positive Akata
cells at 0, 1, 3, 6, 9, 12, 18 and 24 h post-induction (hpi) to
encompass the entire lytic cycle (Takada and Ono, 1989). For
comparison, the quantitative information extracted from the
arrays is summarized in Table 1 using a format similar to that
published by Paulose-Murphy et al. (2001). Specifically, the
Fdoubling in expression time (DT)_ of each gene was measured
by comparing the expression levels at each time point to that at
0 hpi. Thus, DT emphasizes the time that gene expression first
started to increase substantially, at least twofold over the
baseline. For example, expression of BMRF1 (EA-D) had a DT
at 3 hpi, peaked at 6 hpi and then displayed a gradual decline in
expression thereafter. Importantly, the maximal expression and
DT may not be identical, because maximal expression reflects
the amount of RNA accumulation. The DTs may reveal the
differential control of gene expression. For example, the
expression patterns of IE genes Zta and Rta showed increasing
expression at 1 and 3 hpi, respectively. Zta also appeared above
the line of equivalence in a scatter plot comparing the array
data at 0 hpi versus 1 hpi (Fig. 1B), thus reinforcing Zta as the
first gene expressed upon virus reactivation in Akata cells.
Following the expression of IE genes, conserved herpesviral
genes involved in EBV DNA replication, including BALF5
(DNA polymerase), BALF2 (single-stranded DNA binding
protein), BMRF1 (polymerase accessory factor), BBLF2/3
(primase associated factor), BLLF3 (dUTPase) and BaRF1
(ribonucleotide reductase), all had DT at 3 hpi, indicating a state
of preparedness of the molecules required for viral DNA
Fig. 1. Reproducibility and reliability of NTU_EBVArray. RNAs of EBV-
positive Akata cells treated with anti-human IgG for the times indicated were
hybridized to the NTU_EBVArray. The reproducibility of array hybridization
was accessed by cross-comparison of each individual signal obtained from
three independent experiments. (A) Scatterplot comparing signal intensities of
two arrays at 6 h post-induction (hpi). Linear regression analysis gives a line of
gradient 0.91 (R = 0.9759). (B) Scatterplot comparing signal intensities
of arrays at 0 hpi (untreated) and 1 hpi. Linear regression analysis gives a line
of gradient 1.0116 (R = 0.99). The relative expression of Zta indicates it as the
first viral gene expressed upon induction.
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replication, namely BBLF4 (helicase) and BSLF1 (primase),
had DTat 6 to 9 hpi. In general, genes involved in virus structure
and DNA packaging, such as capsid proteins BDLF1, BBRF1,
BcLF1 and BVRF2; glycoproteins BLRF1, BLLF1, BFLF1 and
BALF4; tegument proteinsBNRF1,BPLF1,BOLF1 andBGLF2;
andDNApackaging proteinBDRF1, hadDT between 6 and 12 h.
However, some genes with predicted glycoprotein products
(BILF1, BKRF2 and BXLF2), transport protein (BFRF1) and
capsid protein (BFRF3), had DT at 3 hpi, suggesting possible
biological functions relating to early viral replication.
The viral homologs of cellular genes, which may optimize the
host cell environment for viral replication, were expressed with
various kinetics. For instance, BHRF1 and BALF1 proteins,
which are sequence and functional homologs of the human Bcl-2protein (Henderson et al., 1993; Marshall et al., 1999), were
expressed increasingly at 3 hpi and reached peaks by 12 and 18
hpi, respectively. Two EBV proteins with immune modulating
functions, BARF1-encoded soluble receptor for colony-stimu-
lating factor 1 (vCSF-1R) and BCRF1-encoded IL-10 homo-
logue (vIL-10), showed DT at 6 and 9 hpi, respectively.
Northern blot analysis
To validate the viral gene expression kinetics detected by
microarray, EBV genes, including immediate-early genes BZLF1
(Zta) and BRLF1 (Rta), early genes BMRF1 (EA-D) and BGLF4
(protein kinase) and late gene BLLF1 (glycoprotein), were
selected for Northern blot analysis (Fig. 2). With BRLF1 or
BZLF1 as probes, two bicistronic transcripts of around 3.0 and
3.8 kb were detected (Figs. 2A, B), while the probe for BZLF1
also detected a third transcript of 1.0 kb, showing strong
expression from 3 to 6 hpi, as revealed by the array analysis.
On the whole, the patterns of expression kinetics of BZLF1,
BRLF1, BMRF1, BGLF4 and BLLF1 detected in Northern blots
are consistent with those revealed by microarray analysis.
Hierarchical cluster analysis of EBV gene expression
To correlate the expression pattern of different EBV genes,
hierarchical clustering was used according to the similarity in
gene expression profiles. The results are presented in the
format of a colored mosaic matrix, where each column repre-
sents a time point following induction and every row indicates
the expression pattern of a single ORF (Fig. 3A). Seven gene
groups were assigned according to previously annotated gene
functions: virus gene regulation, DNA replication, nucleotide
metabolism, cellular homolog, virion function and structure,
latency and unknown function. Cluster analysis showed that
genes with similar functions were expressed coordinately. For
example, BALF2, BMRF1, BALF5 and BZLF1, which are
involved in DNA replication, are clustered together at the top
of the matrix. Genes involved in virion assembly, such as
BdRF1, BLLF1, BcLF1 and BBRF3, are clustered at the
bottom. Furthermore, latent genes EBNAs, LMP-1, LMP-2 and
BRAF0, clustered together near the bottom and showed
significant expression at 9–12 h.
In addition to an overall illustration of the classical cascade
of herpesvirus gene expression, subset expression groups were
identified. For instance, genes that are involved in DNA
replication exhibited a split pattern in the expression chart, a
phenomenon suggestive of the progression of viral DNA
synthesis participating in the control of sequential transcription
during lytic replication. Of note, the first cluster contained
several functionally uncharacterized genes, such as BMRF2
and BALF3, and some with putative late functions according to
sequence predictions, such as BILF1, BFRF1, BXLF2 and
BFRF3 (indicated by asterisks in Fig. 3A). Among them,
BILF1 is the recently characterized G-protein-coupled receptor
(Beisser et al., 2005; Paulsen et al., 2005). Thus, our detection
of its early expression kinetics suggests further possible
biological functions related to early viral replication of BILF1.
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overall cascade of EBV gene expression and suggests new
biological functions for genes within same expression cluster.
Identification of viral DNA replication-independent gene
expression
Because some clustering information was unexpected, we
examined further whether the genes with early kinetics are
indeed expressed independent of viral DNA replication. Akata
cells were induced with anti-human IgG in the absence or
presence of the viral DNA polymerase inhibitor PAA, and RNA
was extracted at 24 h post-induction. The number of cells
expressing membrane antigen (MA) was reduced from 60% to
30% in the presence of PAA, as detected by immunofluores-
cence staining with monoclonal antibody 201D6 (Tsai et al.,
1991 and data not shown). The array data indicate that the
expression of many genes was reduced by PAA treatment, and
the 10 most affected genes (50% signal reduction) had delayed
DTs (9 to 12 hpi) during lytic replication (Fig. 4). Meanwhile,
four ORFs with putative structural functions but that were
expressed early, BFRF1, BILF1, BXLF2 and BFRF3, were
relatively resistant to PAA treatment (indicated by asterisks in
Figs. 3A and 4C). Gene expression independent of DNA
replication was analyzed further in TPA-SB-induced Raji cells,
in which the EBV genome lacks the major DNA binding protein
and is unable to complete viral DNA replication (Decaussin et
al., 1995). Quantitative information was arranged in accordance
with the hierarchical clustering of Akata (Fig. 3B). No
hybridization signal to the ORFs was detected within the
deletion region of EBV from Raji cells, including BALF1,
BALF2, BARF1, BZLF2 and EBNA3C (Hatfull et al., 1988).
Most genes expressed in TPA-SB treated Raji cells were
clustered at the top of the Akata matrix, with early kinetics
(Fig. 3B). Detection of four putative structural proteins (BFRF1,
BILF1, BXLF2 and BFRF3) in Raji cells further confirmed that
their expression was independent of viral DNA replication. As
summarized in Table 1, 36 genes showed twofold increased
signals in chemically induced Raji cells (open triangles in Fig.
4C) and 28 were relatively insensitive to PAA in anti-IgG-
induced Akata cells (30% reduction of microarray signals) and
can be grouped as DNA replication-independent genes using
both criteria. The other 8 genes expressed in Raji were affected
by PAA in Akata, including Rta (transactivator), BKRF3 (uracil
DNA glycosylase), BBLF2 (primase associated factor), BPLF1
and BOLF1 (structural proteins), BSRF1, BRRF2 and BORF1
(functions unknown). Thus, the differential expression observed
in PAA/IgG treated Akata and chemically induced Raji could be
due to the different cellular environment, or some of the viral
promoters may be affected directly by PAA.
Reactivation of EBV induces increasing expression of latent
genes
To validate the increasing expression of latent genes,
including EBNA2, EBNA3s, BARF0 and LMP2, between 6
and 12 hpi, as shown in Table 1 and Fig. 3A, RT-PCR usingspecific primer sets was performed to analyze the expression
kinetics of EBNA2, EBNA3A and EBNA3C in anti-IgG-
induced Akata cells (Fig. 5A). RT-PCR products of EBNA-2
and EBNA3s became detectable at 12 hpi and 9 hpi,
respectively. Expression of EBNA-2 protein also was detected
by immunofluorescence in about 1% of IgG-induced Akata
cells at 24 hpi but not in non-induced cells (data not shown).
Among the EBV latent genes, increased expression of
EBNA1 and LMP1 was detected previously during lytic
replication (Zetterberg et al., 1999; Rowe et al., 1992). The
induction of LMP1 was demonstrated recently by a Zta siRNA
strategy to be mediated by Rta (Chang et al., 2004a). In order
to determine whether these EBNAs also were induced by an
Rta mediated pathway, we checked whether the induction of
EBNA-2, -3A and -3C also occurred in chemically induced NA
cells. EBNA3A and EBNA3C, but not EBNA-2, also were
induced in TPA/SB treated NA. We suspect that the RNA
coding for EBNA-2 and EBNA-3 RNA was differentially
spliced in NA, but the effect could also be attributable to
variation in sensitivities of the PCR assays. We then applied the
Zta siRNA strategy to determine whether EBNA3 expression
in NA cells also is mediated by Rta. The block of Zta-
dependent expression of an Rta coactivator, BRRF1 (Segouf-
fin-Cariou et al., 2000), was demonstrated as a control for siZ1
(Fig. 6C, middle panel). Simultaneously, Rta-induced EBNA-
3A and EBNA-3C expression was sustained in the presence of
siZ1 (Fig. 5B), indicating that the lytic induction of EBNA3
was mediated predominantly by Rta.
Identification of genes that are regulated specifically by Rta in
Raji cells
Observing the ability of Rta to stimulate several latent genes
at the lytic stage inspired us to identify Rta responsive promoters
throughout entire viral genome. The array was used to identify
Rta responsive genes in Raji cells, in which it is known that
exogenous Rta expression does not induce Zta expression
(Ragoczy and Miller, 1999). At 48 h post-electroporation of an
Rta expressing plasmid, Rta-induced signals were normalized
against those of the vector control and then compared with those
of TPA-SB-induced Raji cells, which should represent the
synergism of Zta and Rta. The color-coded bar was arranged
according to the Akata cluster (Fig. 3B). Ectopic expression of
Rta in Raji was found to induce the expression of BMRF1,
BaRF1, BMLF1, BHRF1 and BLRF2, but not BZLF1, as
reported previously (Ragoczy and Miller, 1999). In addition, we
found that Rta also activated the expression of BSRF1, BBLF2/
3, BBRF3, Raji LF3, BKRF3, BMRF2, BLLF3, BBLF1,
BGLF5, BKRF4 and BGRF1/BDRF1 in the absence of Zta.
We then searched in the promoter regions of these genes for the
sequence 5V-GNGGN9CCNG-3V, which was identified as an Rta
responsive element (RRE) by a random selection protocol
(Gruffat and Sergeant, 1994). RREs were found immediately
upstream of BSRF1 (662¨646), BBLF2/3 (310¨294),
BBRF3 (459¨443), BMRF2 (819¨803), BLLF3
(907¨891), BBLF1 (263¨247), BKRF4 (325¨
309) and BGRF1/BDRF1 (184¨168) but not Raji LF3,
Table 1
Transcription profiles of EBV genes on array during lytic cyclea
C.-C. Lu et al. / Virology 345 (2006) 358–372362
a Quantitative information of expression ratios in anti-human IgG-induced Akata or chemical (TPA-sodium butyrate)-induced Raji cells extracted from the
microarray images. EBV genes are listed according to their physical location on the EBV genome.
b DT represents the time (hours post-induction) at which a doubling in calibrated ratio was observed comparing to baseline expression (0 hpi) in Akata
cells.
Table 1 (continued)
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that Rta can activate the BGLF5 promoter in a reporter
assay (Hsu et al., 2005), the activation of BLLF3, BBLF1,
BGRF1, BDRF1 and BKRF4 in Rta transfected Raji cells
was further confirmed by RT-PCR (Fig. 6A). Furthermore,
we identified the promoter regions of two uncharacterized
genes with putative enzymatic function. BLLF3 encodes a
putative dUTPase, whereas BGRF1 encodes the first exon of
a putative terminase. BLLF3p-Luc or BGRF1p-Luc was then
cotransfected with an Rta expressing plasmid into Raji cells
for luciferase assay. Indeed, Rta activated the BGRF1
promoter (14.8-fold) and BLLF3 promoter (21.7-fold) in
Raji cells (Fig. 6B). The Rta-dependent induction of BLLF3
expression also was observed in NA cells in the presence of
siZ1 (Fig. 6C, upper panel). Next, to determine whether Rta
can activate BGRF1 and BLLF3 promoters in an EBV-
negative cell background, a reporter assay was performed
in HEK 293 cells (Fig. 6D). Expression of Rta apparently
stimulated the activities of the BLLF3 promoter (6.2-fold)
and the positive control BHLF1 promoter (18.2-fold) but
not the BGRF1 promoter (1.1-fold). These results suggest
that Rta can exert its transactivation effect on the BLLF3
promoter in the absence of other EBV gene products,
while some additional viral or cellular factor(s) may be
required for Rta-dependent regulation of the BGRF1
promoter.
Discussion
In order to gain an overview of the EBV gene expression
program, the NTU_EBVArray was developed with acolorimetric detection system to monitor the genome-wide
expression of viral genes during lytic replication in EBV-
positive cells. To our knowledge, this is the first membrane-
based microarray for monitoring the expression of all EBV
genes simultaneously. The reliability and reproducibility of
this EBV array are shown by a scatter plot analysis (Fig. 1)
and supported further by the result that cluster algorithms
managed the 5V and 3V array elements of two relatively long
ORFs (BLLF1 and BYRF1) which are adjacent to each other
(Fig. 3A). The expression kinetics observed in microarray
analysis also were confirmed by Northern blotting (Fig. 2).
In addition, to display an overall picture of the cascade of
gene expression clusters, we observed (i) the split expression
of genes related to viral DNA replication, (ii) the early
expression of some genes with predicted late function, (iii)
the Rta mediated increasing expression of latent genes at the
lytic stage, (iv) DNA replication independent gene expres-
sion in PAA blocked anti-human IgG-induced Akata cells
and in chemically induced Raji cells, (v) Rta responsive
gene expression in Raji calls and (vi) the Rta mediated
gene expression control using siZta and reporter assay
strategies.
According to our cluster analysis, most EBV genes exhibited
expression patterns that accord with their predicted functions.
We suggest that the split expression of DNA replication proteins
may correlate with the biphasic DNA replication process of
EBV. After initiation, the origin-specific circular latent genome
progresses to an early, theta form structure and later undergoes a
switch to rolling-circle DNA replication which can produce a
burst of viral genomes (Lehman and Boehmer, 1999). The
temporal requirement for genes which function in origin-specific
Fig. 2. Northern blot analyses of EBV transcripts. Individual DNA probes of
(A) Zta, (B) Rta, (C) EA-D, (D) BGLF4 and (E) gp350/220 were selected for
Northern analyses to confirm the results obtained from microarrays. The same
RNA preparations used for the cDNA synthesis step in the microarray were
probed with the PCR-amplified DNA fragments on Northern blots. (F) For
normalization of the amounts of RNA loaded in individual lane, the membranes
were stripped by boiling in 0.1 SSC and 0.1% SDS for 15 min and reprobed
with Glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
C.-C. Lu et al. / Virology 345 (2006) 358–372364initiation or subsequent rolling-circle replication may be
different. This hypothesis is supported by the observation that
CMV uracil DNA glycosylase is required for the early-to-late
switch of viral DNA replication (Courcelle et al., 2001).
Nevertheless, it is also possible that some of the genes expressed
later may not be required for reactivation of DNA replication in
latently infected cells, but rather are packaged into the virion to
function in the next infection cycle (Jenner et al., 2001). Genes
with putative functions in DNA repair and nucleotide metabo-
lism also showed split expression in KSHV (Jenner et al., 2001),
and we have described a similar situation for EBV, suggesting
that sophisticated control of these enzymes may be required to
assure the accuracy of viral DNA replication. Thus, herpes-Fig. 3. Hierarchical cluster analysis of EBV gene expression. (A) Normalized expre
cells were imported into cluster software, and hierarchical clustered using the averag
1998). The data are shown as a color matrix with columns representing different tim
indicate no expression; brighter shades of red, increasing expression; brighter shade
indicated to the side and the putative function of each gene is categorized by diffe
relatedness of patterns of gene expression. The four ORFs with putative virion stru
from Raji cells in the form of log2 normalized means were imported into cluster so
plasmid transfected Raji. Expression pattern, order and annotation of the 85 ORFsviruses are likely to have coevolved their replication and gene
expression strategy.
Based on the hypothesis of a common replication strategy,
annotations of many uncharacterized EBV genes were
predicted from DNA sequence homology with other herpes-
viral ORFs described previously. The cluster information
obtained here proposes new aspects of biological functions
for some of these genes. Looking into the first cluster as an
example, BMRF2 was suggested to encode proteins for virus
envelopes because of the presence of an RGD motif, which
may be a ligand for an integrin coreceptor. We found BMRF2
to display early expression kinetics similar to those of BaRF1
(ribonucleotide reductase) (Fig. 3A). Indeed, the BMRF2
product was not detected in purified EBV particles (Johannsen
et al., 2004), suggesting that BMRF2 may play other roles in
early viral DNA replication. Another example within the first
cluster, BALF3, is a putative terminase component which
should be required for packaging viral DNA into the
procapsid, even though its expression has never been detected.
RNA transcripts covering BALF3 also were detected with
similar early kinetics within anti-IgG-induced Akata cells by
Northern blotting analysis (data not shown). It will be
interesting to determine whether BALF3 also plays certain
roles at an early stage of replication.
Genes with early kinetics in Akata cells, and that were
expressed mainly independent of DNA replication in PAA-
blocked Akata cells or chemically induced Raji cells, included
four with putative late functions: BILF1 (glycoprotein), BFRF1
(tegument protein), BXLF2 (glycoprotein H) and BFRF3
(capsid protein) (Figs. 3A and 4). Among them, BILF1 was
demonstrated recently to be a G-protein-coupled receptor
(Beisser et al., 2005; Paulsen et al., 2005), but the precise
contribution of the other three genes to viral DNA replication
will need further study.
For those genes with later expression kinetics, increased
expression of EBNA2, 3, BARF0 and LMP2 was observed at 6
to 12 hpi in Akata cells, in addition to the latent gene expression
during lytic progression reported previously (Zetterberg et al.,
1999; Rowe et al., 1992; Chang et al., 2004b). The ability of Rta
to transactivate EBNA3A and EBNA3C was demonstrated
further by transfecting Rta and siZta expressing plasmids into
EBV-positive NA cells (Fig. 5B). Because Rta also was shown
to activate LMP-1 expression in the lytic phase, it is quite
possible that Rta is a common activator of lytic expression of
latent genes. In accordance with a previous observation (Rowe
et al., 1992), expression of EBNA-2 protein also was detected
by immunofluoresence in a small number of IgG-induced Akata
cells (data not shown). This suggests these latent products mayssion data from triplicate experiments presented in the form of log2 from Akata
e-linkage algorithm and an uncentered correlation similarity matrix (Eisen et al.,
e points and rows representing the expression pattern of each gene. Black boxes
s of green, decreasing expression. ORFs and corresponding gene products are
rent colors, designated as denoted. The dendrogram on the left represents the
cture function showing early expression are highlighted by asterisks. (B) Data
ftware. Left panel, data from TPA-SB treated Raji; right panel, data from Rta
are compiled in accordance with those described in panel A.
C.-C. Lu et al. / Virology 345 (2006) 358–372 365also contribute to optimizing cellular condition for virus
replication, or the switch from type I latency to type III latency
may facilitate expression of lytic genes (Rowe et al., 1992).Of the uncharacterized genes within the late cluster, we
found Raji LF1 to contain an RGD motif at a.a. 243–245, and
BCRF2 also contains an RGD motif at a.a. 379–381, which
Fig. 4. Lytic EBV gene expression in Akata cells in the presence or absence of PAA. Fifteen micrograms of total RNA harvested from anti-human IgG treated-EBV-
positive Akata cells in the absence (A) or presence (B) of PAA at 24 hpi was reverse transcribed and labeled with biotin-dUTP as described in Materials and methods.
(C) GenPix software was used to quantitate the signal from the array elements. Normalized values from the PAA positive array were divided by that from the
untreated array to derive the fold inhibition of gene expression presented in the form of log2. Dashed lines were placed at 20%, 30% and at 50% reduction of
expression in the presence of PAA. The ORFs that show relatively early expression at 1 to 3 hpi, which were found on the top of the clustering matrix (Fig. 3) are
indicated by open circles. The four ORFs with putative virion structure function and showed early expression are represented by asterisks. Genes expressed in
chemical-induced Raji cells are indicated by open triangles.
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attachment site was identified at a.a. 537–547 of BcRF1.
However, because these proteins were not detected in virions in
a tandem mass analysis of virion components (Johannsen et al.,
2004), the hypothesis that they are components of the virion
remains to be confirmed.
In summary, we identified, using the NTU_EBVArray, 11
previously unknown Rta responsive promoters in Raji cells,
whose Zta expression was not induced by Rta (Fig. 3B). In
chemically induced Raji cells, 36 genes showed twofold
increased signals (open triangles in Fig. 4C), 18 genes were
Rta responsive and another 18 genes could be activated by
Zta along with or synergistically with Rta or Zta. The array
data also were confirmed by RT-PCR analysis and reporter
assays (Figs. 6A, B). Additionally, siZta RNA demonstrated
further similar Rta mediated expression control in EBV-
positive epithelial cells (Fig. 6C). The differential respon-
siveness of BGRF1p-Luc and BLLF3p-Luc to Rta in 293cells thus indicates that Rta-dependent promoters may be
coregulated by other viral or cellular factor(s) in different
cell types. Our observations in this study reveal the genome-
wide expression program of EBV under several different
conditions and suggest coordinate expression control of
different functional clusters. The identification of Rta
responsive promoters in Raji confirms the powerfulness of
this array system for its future application in detecting the
effects of various stimuli and antiviral drugs on EBV
replication.
Materials and methods
Cell culture
Akata cells (Takada et al., 1991) and Raji cells (Pulvertaft,
1965) were cultured in RPMI 1640 medium. NA is an EBV-
positive NPC cell line generated previously by in vitro
Fig. 5. RT-PCR detecting increased expression of EBV latent genes in anti-IgG-induced Akata or Rta transduced NA cells. RT-PCR was performed with indicated
primer sets as described in Materials and methods. (A) Increasing expression of EBNA2, EBNA3A and EBNA3C detected along lytic progression in anti-IgG-
induced Akata cells was detected as 338 bp, 276 bp and 153 bp products, respectively. The 723 bp product observed in EBNA-2 reaction may come from the
unspliced RNA of EBNA-2 (Chen et al., 1995). (B) NA cells were mock transfected or transfected with plasmids expressing siZ1 or siGFP for 48 h, followed by a
second transfection with control vectors (Vec) or Rta-expressing plasmids (Rta) for 24 h. The RT-PCR analysis was performed to detect the expression of EBNA-2,
EBNA-3A, EBNA-3C and GAPDH.
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(Chang et al., 1999), and was maintained in DMEM. HEK293
is a cell line derived from human embryonic kidney. All cell
cultures were supplemented with 10% fetal bovine serum,
penicillin (100 U/ml) and streptomycin (100 Ag/ml) at 37 -C
with 5% CO2. Akata cells (1  106 cells/ml) were induced with
0.5% (v/v) goat-anti human IgG antibody (Cappel Inc.) in the
presence or absence of 200 Ag/ml phosphonoacetic acid (PAA;
Sigma). Raji cells were induced with 40 ng/ml TPA and 3 mM
sodium butyrate (Sigma, St. Louis, MO).
Transfection
NA cells were transfected with different plasmid DNAs
using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. The suppression of Zta expres-
sion in NA cells was performed using Zta-targeted siRNA
as described previously (Chang et al., 2004a). To identify
Rta responsive gene expression, 50 Ag of Rta expressing
plasmid pRTS15 (pSG5-Rta, a gift from Diane Hayward), or
vector control pSG5 (Stratagene Co.) was transfected into 1
 107 Raji cells in 0.2 ml RPMI 1640 medium by
eletroporation at 200 V, 950 AF with a ECM630 system
(BTX Co.).
RNA preparation
Induced or uninduced Akata cells were collected at 0, 1, 3,
6, 9, 12, 18 and 24 h post-induction (hpi) and induced Raji
cells were collected at 0, 12, 24 and 48 hpi. Total RNA was
isolated using the Rezol C and T kit (PROtech technologies
Inc.). RNA samples were treated with 20 U of DNase (LifeTechnologies) in DNase buffer (40 mM Tris–HCl, pH 7.5, 10
mM NaCl and 6 mM MgCl2) for 15 min at RT, terminated by
adding 10 mM EDTA, and purified by phenol/chloroform
extraction and ethanol precipitation.
Construction of EBV microarray membranes
Primers were designed to amplify approximately 1.0 kb
DNA fragments close to the 5V ends of all predicted EBV
ORFs (Table 2) according to the newly revised EBV sequence
(AJ507799 in GenBank). Because the RNA transcripts of
BYRF1 and BLLF1 are longer than 2.0 kb, primers were
also designed to amplify the 3V-end sequences. As control
elements, primers were also designed to amplify six cellular
genes including ribosomal protein S26 (NM_030811),
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(J04038), a-tubulin (K00558), h-actin (NM_001101), de-
fender against programmed cell death (DAD-1, D15057)
and haptoglin (HP, NM_005143). Three plant genes, rubisco
activase precursor (RCA, AY312575), lightharvesting chlor-
ophy II a/b binding protein (LHC, CB330824), ribulose-1,
5-bisphosphate carboxylase/oxygenase large subunit (RBCL,
AB001684), were also included as external controls. All
PCR products were cloned into the pCRII by TA cloning
kit (Stratagene, La Jolla, CA) and sequence verified. The
array elements were amplified with common primers
annealed to vector, and concentrated by evaporation at 95
-C to obtain a concentration of 2–3 Ag/Al before spotted
onto nylon membranes at the National Taiwan University
Hospital Microarray core facility. Each 75-Am-diameter
DNA spot contained more than 10 ng of DNA (Yoneda
et al., 2001).
Fig. 6. RT-PCR analyses and reporter assay of Rta responsive gene expression in EBV-positive and EBV-negative cells. (A) Rta-induced expression of BBLF1,
BLLF3, BGRF1, BDRF1 and BKRF4 was expressed in Rta-transfected Raji cells as detected by RT-PCR with indicated primers as described in Materials and
methods. (B) BGRF1p-Luc or BBLF3-Luc was cotransfected with Rta expressing or vector plasmids into Raji cells. pRL-TK was also cotransfected in each reaction
to serve as a transfection control. Cell lysates were harvested at 48h post-transfection for luciferase assay. After calibration with Renilla luciferase activity, relative
folds of luciferase activities to pGL2-basic are shown. The Rta-induced activation for each reporter is also indicated. (C) NA cells were mock transfected or
transfected with plasmids expressing siZ1 or siGFP for 48 h, followed by a second transfection with control vectors (Vec) or Rta-expressing plasmids (Rta) for 24 h.
The RT-PCR analysis was performed to detect the expression of BLLF3, BRRF1 and GAPDH. PCR products with expected size are indicated. (D) HEK293 cells
were transfected with indicated reporter plasmids in conjunction with either control vector or Rta expressing plasmids. Cell lysates were harvested at 48 h post-
transfection, for luciferase assay. The promoter activity was calculated and shown as the relative luciferase activity as described in Materials and methods. The Rta-
induced activation for each reporter is also indicated. Cotransfection reporter assays in panels B and D were performed at least in 3 independent experiments, and
data from 2 representative experiments are shown with error bars.
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Fifteen micrograms of total RNA of Akata cells or 20
Ag of Raji RNA was reverse transcribed together with 0.25
ng of LHC and RBCL RNAs and labeled with biotin-
dUTP as described (Chen et al., 1998). Hybridization was
performed in triplicate following the protocol described
previously (Chen et al., 1998). After color development, a
purple chromogen generated from the cDNA molecules on
the membrane was scanned using a PowerLook 3000
scanner (Umax, Hsinchu, Taiwan) with an optical resolu-
tion of 3048 by 3048 dpi. The microarray images were
then processed to convert the true-color images into grey
scale images and then quantified by the GenePix micro-
array image analysis program (Axon Instrument, Inc.,
Foster City, CA).Data processing
The local background for each array element was
subtracted and the signal intensity was normalized to the
internal controls. The calibrated ratio for each gene was
obtained from the mean values of induced expression divided
by uninduced expression values. The data set was then
converted to log base 2 and imported into the hierarchical
clustering program (average-linkage algorithm; Eisen et al.,
1998) and visualized with the TreeView software (Eisen et al.,
1998).
Northern blot analyses
Fifteen micrograms of total RNA was loaded into a
denaturing formaldehyde gel, and probed with random-primed
Table 2
EBV primers used for array element synthesis
ORF Forward primer (5V) sequence Reverse primer (3V) sequence Location Product size (b.p.)
BNRF1 GCAAGGATGGAAGAGAGG GGTGCTGGCGTCTCATAAA 1730..2618 889
BCRF1 ATGGAGCGAAGGTTAGTG GGAGCCGTAGGGTCTTTA 9675..10017 343
BCRF2 GCCCCGTTAAACCCAAAG GTCACATAAAGTCCCCCC 12914..13693 780
BYRF1 GCTTGTGTTTTGCTTTATCTG TCCCTCCACATAATCTTCA 36187..37646 1500
BYRF1-5V GCTTGTGTTTTGCTTTATCTG TTTGGGGTGCTTTGATGAGT 36187..37021 835
BYRF1-3V TGCCAGACCAATCAATGC TCCCTCCACATAATCTTCA 36976..37646 671
BHLF1 TGGTTCTGGGGCTCCTC CACGCCCCTCCCTCACT 39912..40231 320
BHRF1 CAGATCTTGTTGAGCAA TAAAGTGCTCGAGAAAATGT 42069..42687 619
BFLF2 ATGAACCTGGGACCTATTGA TGAAAAGTAAACCCGATGGC 44183..44662 480
BFLF1 GCTCGGATTCGTGATGCT ACCCTTGCCACCCAGATGT 44906..46258 1353
BFRF1 GGTCATTGCTCGGATTGTG CGTAACTCGCCTCGTCTTC 46553..47344 792
BFRF2 GTTGTCGGAGGTGGAGAG CACGGGGATAAAACTGGAG 47792..48780 989
BFRF3 TCTCCCCAATGATGTTTTTG TTCGTGCCCTCTACTGTTT 49320..49759 440
BPLF1 CGCAGATGTAGAGGATGAAC CCACCGCCGAAGATGAGTA 58717..59251 535
BOLF1 GCGGCTGGAGAGAAGGAT GTAGCGGAGGGGCAGAC 61816..62917 1102
BORF1 CGCTGCTGTCACTCTCC CTCCTCCAACCGTCAGTA 62921..63953 1033
BORF2 GGACACCCACCACACAGCA TCAAACTCCTCCCCGTAGA 64101..65098 998
BaRF1 TGGAGACTGACGGTTTTACT ACCAATGTCACCCAGGATG 66857..67391 535
BMRF1 GCCGCCGTGTCATTTAGA ACATGGTCTTAAATGAGG 67855..68833 979
BMRF2 ATGTTCTCGTGCAAGCAGC CCCGAGGTGTAAATCTGGT 68830..69392 563
BMLF1 TCCTTGTTGGTTGACTTGG ATGGAGGGCAGCGAAGAA 71038..71771 734
BSLF2 GCCTTGAGCACCTCTGTC TAGCAGCATTTCCTCCAAC 71863..71971 109
BSLF1 GCCGCAGTTTCTCGTGTG ATGTCCGCCCCCGTCGT 73882..74593 712
BSRF1 GGCGGGCTAAACAGAACGA AAGGCGGAGTTGATGAAAGG 74618..75201 584
BLLF3 TGACCCGAGGATCCAAACCC GTCCACACATACGCTACGCC 75354..76180 827
BLRF1 TGCGAAATGGGGAAGGTC TCAGCAGCGTGTTCACAAA 76253..76559 307
BLRF2 CTCGGCTGTTTGTACTTCT TCGTTTGATTCTCGTGGTC 76595..77052 458
BLLF1-3V TACTGGGGTGGGACTTGTT GAGCGGGGGAGATTACTG 77952..78990 1039
BLLF1-5V GGCACTGAATAGGTAGCA GAGACAATGGAGGCAG 78865..79873 1009
BLLF2 TGACCAGCAGCAGCAGAAG ATGTGTCCACCAGTTCGCC 77228..77725 498
BLRF3 GCAGACAAAATGGACAAGG CGCTTTCTCTTCGTACCC 79946..80151 206
BERF1 ACCCATCACACAACAACAAG GCTGCTGTATGCCTTGTAA 80334..80579 246
EBNA3B CCTTGAGCAAAACCTGAAC TTTTAAGAGATTCCATTCCAC 83532..84289 758
EBNA3C CAGGCAGCGTCTTCAGG ACTGGAGGTGGTTGATGG 86600..87604 1005
BZLF2 ATTAAGGGGATCCAAGGTGA TGGTTTCATTTAAGCAGGT 89131..89808 678
BZLF1 AAGGGAATGCGTTACTACA TTGCTGAAGATGATGGACC 90251..90876 626
BRLF1 AAGTGTCTAAAATAAGCTGGT GATGAACTCGAAAGTCTCCCG 90794..93012 918
BRRF1 ATGGCTAGTAGTAACAGAG AACAGACGCAGGTAAGAGAA 92894..93848 955
BRRF2 GTATGAGTGGGCAGCAGAG CTTTATTAGACGACGCTCAG 94012..95632 1621
BKRF1 GATCCCATGGACCCTGTAGGGGAAGCC AAACTGCAGGATCCTCACTCCTGCCCTTC 96881..97607 727
BKRF2 ATCATGCGTGCTGTTGGTGT TGAGGGCGGAGCTGCTTCG 97667..97970 304
BKRF3 TTGTTAACCACCCTGGAGAC AGCCCCTTCTCACGCAAAAA 97988..98807 820
BKRF4 ATTGGAGGCTGTAGAGGGGT CTTAATGGGGGGGGTGGTTT 98819..99476 658
BBLF4 GTAGTGCGCGTGAGTTCTTT CTCTCGTCCACGTTCATGTT 99553..101940 2388
BBRF1 AGGCGTGTGAGGTCATGTTC TTGCGGTCCACCAGGTTGTT 101902..102961 1060
BBRF2 ACGTCCCTGAGTTCTACAAT AGGGAATTATTTTTGAGACC 103787..104494 708
BBLF3 GTAAATCTGTCTCTCGCGTG GCAAGGCGTGAAAGACTCGG 104519..105090 572
BBLF2 AGGTTCAGGTCCAGTAGCA ATGTTTTAAAGGGTCCAGTC 105738..106788 1051
BBRF3 ACGCACTGGTTGATTACGGG TAAAACGGAGGAGACGAGGG 106988..108027 1040
BBLF1 TGCCTCCCCCTTTACCCATT ATGGGTGCCCTCTGGTCTCT 108425..108686 262
BGLF5 ATGACCGGGGCCCAGTTTG AGACTGAGGCCTTTGTCC 109136..109974 839
BGLF4 GAAGATCTGTTGCGGTCGTGGAGGG GATCGGATCCATGGATGTGAATATG 110639..111327 689
BGLF3 GAGGCTCTTAGTTGCTGG TCTGTGTTTTGAGGTGTTTG 111614..112304 691
BGRF1 CATCGGGTCATCGGGCAT TCCAGCGTCATTTCTTCCAA 112610..113284 675
BGLF2 GCAGCAGACAAGGACAGG ATATTCTGGCACGTCATGG 113859..114600 742
BGLF1 GACCCGACCCCCACAG CGACACGGTTATGGCAGA 115305..116015 711
BDLF4 ACCACATCCACCACCTTCTC AGTTCCATCTCCCGTTACCT 116210..116623 414
BDRF1 AGTGCCTCGCTTCTTATC GTGTGCTTCTGTGTTGTT 116898..118027 1130
BDLF3 TCGTCCAGGGGCTTGTTCTT GTTCAGTAGAGTATTGGGTGT 118132..118847 716
BDLF2 GAGGTATGCAGGGAATGAG ACAATCAGCCGGGAGGAAG 118869..120038 1170
BDLF1 AGGCCCCAAATTAAATAGTGA CATGCCACCGTGAAGTTAG 120172..120642 471
BcLF1 GGTCGTGTACTTGGGATTG CCCCATCTCCCTCTTACC 123919..125186 1268
BcRF1 CGCTACTTGTCTCATCACC CTCCCTCCGCCGTTACTCT 125603..126060 459
(continued on next page)
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BTRF1 TGGGACTGCCTGGGGAAAA TTTCCTTCTTGACCTTGAT 127525..128583 1059
BXLF2 ACATGCTCATCTCCCTTCTC TTTTGCCTGGTGTTGCTATG 130170..130729 560
BXLF1 TCCGCTCGAGGTCCCGATTTCCCCT CATATGGCTGGATTTCCA 130752..132572 1821
BXRF1 TTTCGTTTTCAGGGGACTCA CACGCGGAGCAGCCTATTT 132491..133330 840
BVRF1 GTAGTGGCCTTCTCTGATG TCCGAGGCTGAGAACTGAC 133397..134775 1379
BVRF2 GGTCGGCTCAGTCTTTGG GGCATTGGCGTCATTCTC 135796..136186 391
BdRF1 CAGACCCCGCTACCCTAC GGTGGGCTCCTTAGACTG 136553..137377 825
BILF2 GACTGGTGCTTGTGGTGTGG CTGTGTGGGGTCTGTTTGTG 137714..138188 475
Raji LF3 TTCCAGGCATAGGTTAC AAAGGGACAGGGGGAGA 140426..140749 324
Raji LF2 GCGGATGTCTGTGGATTC AACCCCTACCTCTACCTG 149452..149865 414
Raji LF1 GACGGGCAAGGTGAGAGT TGGACATACAGGTGGACAG 150339..150841 503
BILF1 AGTAGCGGGCAACGAGAGA CTGGGTGCTGGGAAAAATGA 151843..152380 538
BALF5 TTAGAATGGTGGCCGGGCT CTTTCCCTGCCTCTCCATC 155635..156292 658
ECRF4 GAGGCTGAGCTTGTCCC TCCCATCCCAACAGTGTG 154936..155666 731
BALF4 TGTTCTGCCTCTTCTGCTCC TGTATGTAGACCGCGACGGA 157390..158401 1012
BALF3 GGCACAAACTTACATCGACT AACCTTGTGGATGCCATGGG 160557..161264 708
BARF0 CTGTAGAAGCTGTTGAAGGA GAAGAGAATCAATAGCGTGT 159134..160531 1398
BALF2 ATGCAGGGTGCACAGACT CGGAATTGGTGGCAAAGA 163309..164312 1004
BALF1 ATTTCAGGAAGTCAGTCAGG AGGAGGAGCTGAGCGATGAA 164405..165074 670
BARF1 ATGGCCAGGTTCATCGCT TTGCGACAAGTATCCAGA 165708..166046 339
BNLF2 ATGGGGTCCCTAGAAATGGT GCACATTGGGTTTATTGTAGTG 166103..5856 1951
BNLF1 CCGTGGGGGTCGTCATC CATCCTGCTCATTATTGCT 167730..168410 681
Table 2 (continued)
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hyb buffer (Ambion, Austin, TX) after transfer onto a nylon
membrane.
RT-PCR
Reverse transcription reaction contained 5 Ag total RNA, 50
Ag/ml oligo(dT)15 (Amersham Pharmacia), 1 first strand
buffer, 10 mM DTT, 2 mM dNTP and 300 units of Superscript
II reverse transcriptase (Invitrogen) in a volume of 20 Al. After
incubation at 42 -C for 90 min, RT reaction was stopped by 94
-C for 5 min. The RT products were then subjected to the
subsequent PCR analysis. The primers for BLLF3, BGRF1,
BBLF1 and BRRF1 transcripts were listed in Table 2. For
detecting BDRF1, forward primer, CAGGTCACCGTCTC-
CAACA (at 117,851 to 117,869) and reverse primer,
CTCGAGTTAAACTTTCTTGAACGTGT (at 118,041 to
118,063) were used. Other primers designed in previous studies
were used to detect EBNA2 (Chen et al., 1995), EBNA3A,
EBNA3C and GAPDH (Chang et al., 1998, 2004b).
Reporter assay
For Rta transactivation in epithelial cells, 50 ng pBHLF1p-
Luc (containing genome 41,270 to 42,070 in a pGL2-basic
background), pBGRF1p-Luc (114499 to 112649 in a pGL2-
basic background) or pBLLF3p-Luc (77,387 to 76,187 in a
pGL2-basic background), 20 ng pRTS15 or pSG5 and 50 ng of
pRL-TK (as transfection efficiency control) were cotransfected
into HEK293 cells seeded in 12-well plates, using the calcium
phosphate method (Chen and Okayama, 1987). To demonstrate
Rta transactivation activity in Raji, 10 Ag pBGRF1p-Luc or
pBLLF3p-Luc, 35 Ag pRT15 or pSG5 and 5 Ag of pRL-TK
were cotransfected into 1  107 Raji cells. At 48 h post-transfection, cells were harvested and subjected to luciferase
assay with a Dual-Glo assay kit (Promega) according to the
manufacturer’s instructions. Relative luciferase activity of
individual transfection was calibrated by Renilla luciferase
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